Marqeta — Blitz Index 43 (C)
Card-issuing infrastructure with blitz volume and a halved take rate; Block's 2028 renewal is the whole story.
Confidence: High · Category: platforms
Score breakdown
| Section | Score | Detail |
|---|---|---|
| A · Speed | 15 / 25 | TPV +31% to $382.5B, yet the take rate halved (0.304% → 0.146%) — volume blitz, price retreat |
| B · Moat | 29 / 60 | Infrastructure quality, not a network: defensibility ends at each individual customer contract |
| C · Creative destruction | 8 / 15 | Card issuing became an API call; embedded finance is the new order it rides |
| D · BlitzFailing | −9 | One customer (Block) at 41–45% of revenue, a $13.0M securities settlement, founder voting control of 46.9% |
Radar axes (0–100): Moat 48.3 · Speed 60 · Creative 53.3.
Watch item
Gates: G1 ✓ · G2 ✓. Bar ≈ $7.0B (FY2026E net revenue × 10), computed on net revenue only — TPV is volume, not revenue.
Strengths
- TPV +31.4% (FY2025) and +31.8% (Q2 2026) — volume growth is durable
- Two straight profitable quarters and a 21% adjusted EBITDA margin — the profitability turn has started
- Gross margin steady at 70% with operating cash flow of $162.6M, up three years running
- Concentration is easing on paper: Block 68% → 41%, Sutton 76% → 58%
Concerns
- Take rate 0.304% → 0.146% and still falling in Q2 2026 — the floor is unconfirmed
- FY2026 net revenue guidance of +12–13% makes the volume/revenue gap explicit
- The Block renewal (June 2028) can reprice close to half of revenue in a single negotiation
- CEO and CFO both changed across 2025–2026 — execution continuity is an open file
More Platforms companies
Other Platforms names on the Blitz Index, highest score first: Alphabet (82/A), Meta (78/B), Snowflake (76/B).
Next earnings
Nov 3, 2026 · After close · Confirmed
Coverage
Marqeta, Inc. · Q3 2026 due Nov 3, 2026 (AMC) · Score 43 · Grade C
Embed this score
Copy the HTML below to show this score on your site. The badge links back to this page and updates automatically when the score changes.
BlitzLab scores businesses against a scholar’s standard — not investment advice. No price targets, no buy/sell recommendations. Figures are from SEC filings (XBRL) as labeled in the source scorecard.